| ▲ | estearum 20 hours ago | ||||||||||||||||
1) No, not even theoretically. Since "prove" means different things to different organizations. 2) I didn't say there are no additional requirements. For example, you have to fill out some paperwork. I said they are trivial compared to actually making a drug that works and proving that it works. Drugs do not die because of the approval processes, they die because it's unfathomably hard to make drugs that work and then to prove that they work. | |||||||||||||||||
| ▲ | AnthonyMouse 18 hours ago | parent [-] | ||||||||||||||||
> No, not even theoretically. Since "prove" means different things to different organizations. This is circular logic. It's just defining "prove" to be coterminous with what a given set of regulations require in order to claim that it's the "proving" which is the hard part and not the complying with the regulations. For it not to be that, "prove" would need an independent objective meaning, and then we're back to non-overlapping circles. > I said they are trivial compared to actually making a drug that works and proving that it works. If this was the case then there wouldn't be drugs that are prohibited in the US but not other first world countries (or vice versa) specifically because they can't be patented or the patents have already expired, and as a result no one pays for the prohibitively expensive regulatory process to get them approved. They've already been proven in the other countries -- higher numbers of patients than you have in normal clinical trials -- but because the approval rules are excessively rigid and unreasonable, that doesn't count. | |||||||||||||||||
| |||||||||||||||||